v3.26.3
Segment Information - Summary of Additional Information On Company's Net loss Including Segment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
General and administrative expense                  
Other income and expense, net $ (2,099)     $ (1,365)     $ (6,389) $ (7,099)  
Net loss (38,300) $ (25,867) $ (20,196) (20,283) $ (26,103) $ (32,656) (84,363) (79,042) $ (100,000)
Operating Segments                  
Research and development expense                  
LX2006 12,660     5,135     26,104 12,072  
LX2020 2,746     3,137     5,753 12,058  
Other programs 1,569     845     4,334 2,192  
Employee compensation expenses 3,847     3,374     11,703 11,833  
Lab-related costs and supplies 558     449     1,553 1,128  
Acquired in-process research and development 9,874     0     9,874 0  
All other research and development expense 3,242     2,755     9,905 8,304  
General and administrative expense                  
Employee compensation expenses 2,165     1,867     6,124 6,156  
All other general and administrative expense 3,738     4,086     15,402 32,398  
Other income and expense, net (2,099)     (1,365)     (6,389) (7,099)  
Net loss $ (38,300)     $ (20,283)     $ (84,363) $ (79,042)